Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Researchers identify specific metabolic profiles that predict risk of heart attack and death

Tiny bits of molecular "trash" found in circulating blood appear to be good predictors of cardiovascular disease and untimely death, say researchers at Duke University Medical Center.

19 Feb 2010

Sepracor to merge with Dainippon Sumitomo Pharma America

Sepracor Inc. and Dainippon Sumitomo Pharma Co., Ltd. (DSP) today announce the resignation of Adrian Adams as President and Chief Executive Officer and Director of Sepracor and as Executive Officer of DSP, effective immediately, and the appointment of Saburo Hamanaka as Chairman of Sepracor and Executive Officer of DSP. Sepracor and DSP also announce the planned merger of Sepracor and DSP’s subsidiary, Dainippon Sumitomo Pharma America, Inc. (DSPA), to be completed on April 1, 2010, with Sepracor as the surviving company.

19 Feb 2010

NBCH's annual report: How America's health plans are doing to improve care and control costs for diabetes

Today the National Business Coalition on Health issued its annual report on how America's health plans are doing to improve care and control costs for diabetes. The analysis is based on health plan survey data from NBCH's eValue8™ program, the nation's leading Request for Information (RFI) tool used by employers, coalitions and their purchaser members to set expectations and measure health plan performance.

19 Feb 2010

Two UCSF scientists selected for Potamkin Prize for their achievements in research on dementias

Two UCSF scientists have been selected for the American Academy of Neurology's prestigious Potamkin Prize, for their "outstanding achievements" in research on dementias.

19 Feb 2010

Gladstone MD receives Potamkin Prize for identifying new avenues in Alzheimer's research

Lennart Mucke, MD, Director of the Gladstone Institute of Neurological Disease (GIND), has been named a recipient of the American Academy of Neurology's prestigious Potamkin Prize.

19 Feb 2010

Norwegian government task force suggests formation of single company to commercialise biomaterial assets

Having studied the ethical, judicial and political arguments, the Norwegian government task force has suggested that a single nationwide company should be formed to commercialise biomaterials assets from the country’s various sources. The task force has also recommended HUNT Biosciences be a model for the national company.

18 Feb 2010

Pfizer Canada accepts entries for seventh round of competition for Pfizer CVRAP

Pfizer Canada is currently accepting entries for its seventh round of competition for the Pfizer Cardiovascular Research Awards program (CVRAP). The program, first launched in October 2005, was developed to fund and support independent cardiovascular research in Canada.

18 Feb 2010

AHA Scientific Statement: Only 33% of annual PCIs are performed in women

President Clinton’s stent surgery brought new focus to America’s number-one killer, but it did little to expose the bias that is often present when women seek treatment for a heart attack.

18 Feb 2010

HealthTrust Purchasing Group signs 3-year vascular graft procurement contract with MAQUET Cardiovascular

MAQUET Cardiovascular, LLC, a leading provider of cardiovascular technologies, announced today that it has signed a three year contract with HealthTrust Purchasing Group, LP to provide woven and knitted textile vascular grafts to the HealthTrust membership. The contract includes the HEMASHIELD product line and other vascular grafts, which are used to surgically repair or replace damaged blood vessels, including the aorta.

18 Feb 2010

People who are happy and content are less likely to develop heart disease

People who are usually happy, enthusiastic and content are less likely to develop heart disease than those who tend not to be happy, according to a major new study published today (Thursday 18 February).

18 Feb 2010

Genzyme announces fourth-quarter and full-year 2009 financial results

Genzyme Corp., a diversified, global biotechnology company, today announced fourth-quarter and full year 2009 financial results and provided 2010 guidance that reflects growth across its businesses and a focus on strengthening core areas of the company.

18 Feb 2010

St. David's Healthcare to acquire Texas-based multi-hospital regional healthcare system

St. David's HealthCare and MedCath Corporation today announced an agreement for St. David's HealthCare to acquire the Heart Hospital of Austin. St. David's HealthCare is a multi-hospital regional healthcare system based in Austin, Texas.

17 Feb 2010

MedCath to sell Heart Hospital of Austin to St. David's Healthcare Partnership

MedCath Corporation and its physician partners announced today that they have entered into a definitive agreement to sell substantially all the assets of Heart Hospital of Austin to St. David's Healthcare Partnership, L.P. ("St. David's"). The transaction is expected to close during MedCath's third fiscal quarter of 2010, subject to customary closing conditions and regulatory requirements.

17 Feb 2010

Educational event: SCAI highlights gender and racial disparities in treating cardiovascular disease

The Society for Cardiovascular Angiography and Interventions (SCAI) today announced an educational event for the public highlighting the gender and racial disparities in the prevention and treatment of cardiovascular disease. The "Know What Counts" educational program titled, "The Path to Health Care Equity: Identifying and Solving Racial, Ethnic, and Gender Disparities in Health Care in the New Century," will feature a distinguished physician panel, along with a keynote address by U.S. Senator Ben Cardin.

17 Feb 2010

Study: Multiple genetic markers linked with CVD not associated with improvement in CVD risk prediction

Creation of a genetic risk score comprised of multiple genetic markers associated with cardiovascular disease (CVD) was not associated with significant improvement in CVD risk prediction in a study that included more than 19,000 women, according to a study in the February 17 issue of JAMA.

17 Feb 2010

Low RVEF increases risk of death in patients with systolic heart failure

New research from the University of Alabama at Birmingham (UAB) suggests that the ability of right side of the heart to pump blood may be an indication of the risk of death to heart-failure patients whose condition is caused by low function by the left side of their heart.

17 Feb 2010

GeneNews granted second U.S. patent for Sentinel Principle technology

GeneNews Limited, a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced that it has been granted a second U.S. patent for its core platform technology, the Sentinel Principle(R). U.S. Patent # 7,662,558, entitled "Method of profiling gene expression in a human subject."

17 Feb 2010

First field study shows lack of exposure to morning light delays sleep in teenagers

The first field study on the impact of light on teenagers' sleeping habits finds that insufficient daily morning light exposure contributes to teenagers not getting enough sleep.

17 Feb 2010

Postmenopausal women undergoing combination hormone therapy at increased risk of heart disease: WHI confirms

New analyses from the Women's Health Initiative (WHI) confirm that combination hormone therapy increases the risk of heart disease in healthy postmenopausal women. Researchers report a trend toward an increased risk of heart disease during the first two years of hormone therapy among women who began therapy within 10 years of menopause, and a more marked elevation of risk among women who began hormone therapy more than 10 years after menopause. Analyses indicate that overall a woman's risk of heart disease more than doubles within the first two years of taking combination HT.

17 Feb 2010

Scienta Health signs agreement with Partners HealthCare to provide advanced acute care to its clients

Scienta Health today announced that it has entered into an agreement with Boston-based Partners HealthCare, the leading academic medical network in the U.S. Partners HealthCare includes major teaching hospitals affiliated with Harvard Medical School: the Massachusetts General Hospital, Brigham and Women's Hospital, Dana-Farber Cancer Institute, McLean Hospital, a treatment and research leader in mental illness, chemical dependency and learning disabilities; and Spaulding Rehabilitation Hospital, a top-ranked rehabilitation facility.

17 Feb 2010

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Researchers identify specific metabolic profiles that predict risk of heart attack and death

Sepracor to merge with Dainippon Sumitomo Pharma America

NBCH's annual report: How America's health plans are doing to improve care and control costs for diabetes

Two UCSF scientists selected for Potamkin Prize for their achievements in research on dementias

Gladstone MD receives Potamkin Prize for identifying new avenues in Alzheimer's research

Norwegian government task force suggests formation of single company to commercialise biomaterial assets

Pfizer Canada accepts entries for seventh round of competition for Pfizer CVRAP

AHA Scientific Statement: Only 33% of annual PCIs are performed in women

HealthTrust Purchasing Group signs 3-year vascular graft procurement contract with MAQUET Cardiovascular

People who are happy and content are less likely to develop heart disease

Genzyme announces fourth-quarter and full-year 2009 financial results

St. David's Healthcare to acquire Texas-based multi-hospital regional healthcare system

MedCath to sell Heart Hospital of Austin to St. David's Healthcare Partnership

Educational event: SCAI highlights gender and racial disparities in treating cardiovascular disease

Study: Multiple genetic markers linked with CVD not associated with improvement in CVD risk prediction

Low RVEF increases risk of death in patients with systolic heart failure

GeneNews granted second U.S. patent for Sentinel Principle technology

First field study shows lack of exposure to morning light delays sleep in teenagers

Postmenopausal women undergoing combination hormone therapy at increased risk of heart disease: WHI confirms

Scienta Health signs agreement with Partners HealthCare to provide advanced acute care to its clients

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in